Home > Our Doctors > Find a Doctor

Select Physicians to compare
Photo of Albert Keshgegian, M.D.

Albert A Keshgegian, M.D. , PhD

Request an Appointment

Need help deciding?
Contact 1.866.CALL.MLH or
484.580.1000 for assistance.

Medical Group:

Main Line Health Laboratories
Specialties Accepting New Patients
Pathology
  Board Certified in 1979
Yes
Pathology
  Board Certified in 1979
Yes
Age: 65     Gender: M

Medical School:
Univ. of PA School of Medicine

Residency:
Hospital of the University of Pennsylvania

Primary Affiliation:  Lankenau Medical Center

* Members of the Main Line Health medical staff are affiliated with Bryn Mawr Hospital, Lankenau Medical Center, Paoli Hospital and Riddle Hospital.

Main Line Health Laboratories   (view other physicians at this practice)

Office Information

Location:
Lankenau Medical Center Pathology
100 East Lancaster Avenue
Wynnewood, PA  19096

TEL: 484.476.2613 FAX: 484.476.8456
View Map | Get Directions

hours icon Hours: Weekdays
 
Main Line Health Laboratories
100 East Lancaster Avenue
Wynnewood, PA  19096

TEL: 484.476.2613 FAX: 484.476.8456

View Map | Get Directions

Hours:Weekdays



Titles

Academic Titles:
Clinical Professor of Pathology, Anatomy & Cell Biology - Jefferson Medical College

Clinical/Dept Titles:

System Chairman, Department of Pathology, Main Line Hospitals; Medical Director, Main Line Health Laboratories; Medical Director, Clinical Chemistry;
Chief of Pathology, Lankenau Medical Center

Recent Clinical Studies Published

Keshgegian, AA (1995). ErbB-2 oncoprotein overexpression in breast carcinoma: Inverse correlation with biochemically and immunohistochemically determined hormone receptors. Breast Ca. Res. Treat 35, 101-210.

Keshgegian, AA and Cnann, A. (1995). Proliferation Markers in Breast Carcinoma: Mitotic Figure Count, S-Phase Fraction, Proliferating Cell Nuclear Antigen, Ki-67 and MIB-1. Amer. J. Clin. Pathol. 104, 42-49.

Keshgegian, AA and Cnann A. (1996). Estrogen Receptor Negative, Progesterone Receptor Positive Breast Carcinoma: Poor Clinical Outcome. Arch. Pathol. Lab. Med. 120, 970-973.

Keshgegian, AA and Cnaan A. (1997). ErbB-2 Oncoprotein Expression in Breast Carcinoma: Poor Prognosis Associated with High Degree of Cytoplasmic Positivity Using CB11 Antibody. Amer.J. Clin. Pathol., 108, 471-478.

Soler AP, Harner GD, Knudsen KA, McBrearty FX, Grujic E, Salazar H, Han AC, and Keshgegian, AA. (1997). The Expression of P-Cadherin identifies PSA-Negative cells in Epithelial Tissues of Male Sexual Accessory Organs and in Prostatic Carcinomas: Implications for Prostate Cancer Biology, Amer. J. Pathol. 151, 471-478.

Keshgegian, AA, Johndyon E, and Cnaan A. (1998). Bc1-2 Oncoprotein Positivity and High MIB-1 (Ki-67) Proliferate Rate Are Independent Predictive Markers for Recurrence in Prostate Carcinoma. Amer. J. Clin. Pathol., 110, 443-449.

Soler AP, Knudsen KA, Salazar H, Han AC, Keshgegian, AA. (1999) P-Caderin Expression in Breast Carcinoma Indicates Por Survival. Cancer 86, 1263-1272.

Gupta D, Shidham V, Zemba-Palko V, Keshgegian AA. (2000). Primary Bilateral Mucosa-Associated Lymphoid Tissue Lymphoma of the Breast and Atypical Ductal Hyperplasia and Localized Amyloidosis: A Case Report and Review of the Literature. Arch. Pathol. Lab Med. 124, 1233-1236.

Knudsen KA, Lin CY, Johnson KR, Wheelock MJ, Keshgegian AA, Soler, AP. (2002) Lack of Correlation Between Serum Levels of E and P-Cadherin Fragments and the Presence of Breast Cancer. Hum. Pathol. 31, 961-965.

Community/Team Clinical Affiliations

Member, Quality Council, Main Line Hospitals.

Member, Medical Executive Committee, Main Line Hospitals.

Member, Transfusion Committee, Main Line Hospitals.

Inspector, College of American Pathologists Laboratory Accreditation Program.

Member, Medical Advisory Committee, American Red Cross, Penn-Jersey Region.

Member, Board of Directors, The John S. Sharpe Research Foundation, Bryn Mawr Hospital.

Philadelphia Area Division Commissioner, College of American Pathologists Commission on Laboratory Accreditation.

Current Memberships and Activities

College of American Pathologists


American Society of Clinical Pathologists


American Association for Clinical Chemistry

GENERAL

Specialties: Pathology (Board Certified in 1979) - Accepting New Patients
Pathology (Board Certified in 1979) - Accepting New Patients
Age: 65     Gender: M

Medical School:
Univ. of PA School of Medicine

Residency:
Hospital of the University of Pennsylvania

Primary Affiliation:  Lankenau Medical Center

* Members of the Main Line Health medical staff are affiliated with Bryn Mawr Hospital, Lankenau Medical Center, Paoli Hospital and Riddle Hospital.

Titles

Academic Titles:
Clinical Professor of Pathology, Anatomy & Cell Biology - Jefferson Medical College

Clinical/Dept Titles:

System Chairman, Department of Pathology, Main Line Hospitals; Medical Director, Main Line Health Laboratories; Medical Director, Clinical Chemistry;
Chief of Pathology, Lankenau Medical Center


PRACTICE

Practice Name:
Main Line Health Laboratories

appointment icon Location:

Lankenau Medical Center Pathology
100 East Lancaster Avenue
Wynnewood, PA  19096
TEL: 484.476.2613 FAX: 484.476.8456
hours icon Hours: Weekdays

PUBLICATIONS & CITATIONS

Recent Clinical Studies Published

Keshgegian, AA (1995). ErbB-2 oncoprotein overexpression in breast carcinoma: Inverse correlation with biochemically and immunohistochemically determined hormone receptors. Breast Ca. Res. Treat 35, 101-210.

Keshgegian, AA and Cnann, A. (1995). Proliferation Markers in Breast Carcinoma: Mitotic Figure Count, S-Phase Fraction, Proliferating Cell Nuclear Antigen, Ki-67 and MIB-1. Amer. J. Clin. Pathol. 104, 42-49.

Keshgegian, AA and Cnann A. (1996). Estrogen Receptor Negative, Progesterone Receptor Positive Breast Carcinoma: Poor Clinical Outcome. Arch. Pathol. Lab. Med. 120, 970-973.

Keshgegian, AA and Cnaan A. (1997). ErbB-2 Oncoprotein Expression in Breast Carcinoma: Poor Prognosis Associated with High Degree of Cytoplasmic Positivity Using CB11 Antibody. Amer.J. Clin. Pathol., 108, 471-478.

Soler AP, Harner GD, Knudsen KA, McBrearty FX, Grujic E, Salazar H, Han AC, and Keshgegian, AA. (1997). The Expression of P-Cadherin identifies PSA-Negative cells in Epithelial Tissues of Male Sexual Accessory Organs and in Prostatic Carcinomas: Implications for Prostate Cancer Biology, Amer. J. Pathol. 151, 471-478.

Keshgegian, AA, Johndyon E, and Cnaan A. (1998). Bc1-2 Oncoprotein Positivity and High MIB-1 (Ki-67) Proliferate Rate Are Independent Predictive Markers for Recurrence in Prostate Carcinoma. Amer. J. Clin. Pathol., 110, 443-449.

Soler AP, Knudsen KA, Salazar H, Han AC, Keshgegian, AA. (1999) P-Caderin Expression in Breast Carcinoma Indicates Por Survival. Cancer 86, 1263-1272.

Gupta D, Shidham V, Zemba-Palko V, Keshgegian AA. (2000). Primary Bilateral Mucosa-Associated Lymphoid Tissue Lymphoma of the Breast and Atypical Ductal Hyperplasia and Localized Amyloidosis: A Case Report and Review of the Literature. Arch. Pathol. Lab Med. 124, 1233-1236.

Knudsen KA, Lin CY, Johnson KR, Wheelock MJ, Keshgegian AA, Soler, AP. (2002) Lack of Correlation Between Serum Levels of E and P-Cadherin Fragments and the Presence of Breast Cancer. Hum. Pathol. 31, 961-965.

Community/Team Clinical Affiliations

Member, Quality Council, Main Line Hospitals.

Member, Medical Executive Committee, Main Line Hospitals.

Member, Transfusion Committee, Main Line Hospitals.

Inspector, College of American Pathologists Laboratory Accreditation Program.

Member, Medical Advisory Committee, American Red Cross, Penn-Jersey Region.

Member, Board of Directors, The John S. Sharpe Research Foundation, Bryn Mawr Hospital.

Philadelphia Area Division Commissioner, College of American Pathologists Commission on Laboratory Accreditation.

Current Memberships and Activities

College of American Pathologists


American Society of Clinical Pathologists


American Association for Clinical Chemistry

Membership on the medical staff of any of our hospitals does not constitute an employment or agency relationship.

Compare Physicians
  •  

Connect with MLH

New Appointments
1.866.CALL.MLH

 Well Ahead Newsletter


STAY CONNECTED

Copyright 2014 Main Line Health

Printed from: www.mainlinehealth.org/phy/Page.asp?PageID=PHY000730

The information provided in this Web site is for informational purposes only. It is not a substitute for medical advice. All medical information presented should be discussed with your healthcare professional. See additional Terms of Use at www.mainlinehealth.org/terms. For more information, call 1.866.CALL.MLH.